Summary The Global Diabetes Compact is a WHO-driven initiative uniting stakeholders
around goals of reducing diabetes risk and ensuring that people with diabetes have …

Abstract Background Cardiovascular diseases (CVDs) constitute major comorbidities in type
2 diabetes mellitus (T2DM), contributing substantially to treatment costs for T2DM. An …

Aim Diabetic foot ulcers are associated with an increased risk of death. We evaluated
whether ulcer severity at presentation predicts mortality. Methods Patients from a national …

Background Sulfonylureas are an effective and inexpensive treatment for type 2 diabetes.
There is conflicting data about the safety of these drugs regarding mortality and …

We designed a systematic literature review to identify available evidence on adherence to
and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic …

Background Microvascular disease is associated with a high risk of macrovascular events in
patients with type 2 diabetes, but the impact of macrovascular disease on the risk of …

Objective: To evaluate the effectiveness and safety of real-time continuous glucose
monitoring (CGM) in adults 65 years old and older with type 2 diabetes (T2D) using basal …

Objectives: To estimate the clinical and economic burden of type 2 diabetes (T2D) in
established (EST) and emerging markets (EMG). Methods: Three systematic literature …

Objectives To quantify the relationship between a national primary care pay-for-performance
programme, the UK's Quality and Outcomes Framework (QOF), and all-cause and cause …

Background Although hypertension is a well-known risk factor for chronic kidney disease
(CKD), the blood pressure (BP) at which antihypertensive interventions should be initiated …